Journal ArticleDOI
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Marc Arbyn,Guglielmo Ronco,Ahti Anttila,Chris J.L.M. Meijer,Mario Poljak,Gina Ogilvie,George Koliopoulos,Pontus Naucler,Rengaswamy Sankaranarayanan,Julian Peto +9 more
TLDR
There exists a substantial evidence base to support that HPV testing is advantageous both in triage of women with equivocal abnormal cytology, in surveillance after treatment of CIN lesions and in primary screening of women aged 30 years or older, however, the possible advantages offered by HPV-based screening require a well organised program with good compliance with screening and triage policies.About:
This article is published in Vaccine.The article was published on 2012-11-20. It has received 719 citations till now. The article focuses on the topics: Cervical intraepithelial neoplasia & Cervical cancer.read more
Citations
More filters
Journal ArticleDOI
Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis
Marc Arbyn,Elisabete Weiderpass,Laia Bruni,Silvia de Sanjosé,Mona Saraiya,Jacques Ferlay,Freddie Bray +6 more
TL;DR: The global scale-up of HPV vaccination and HPV-based screening—including self-sampling—has potential to make cervical cancer a rare disease in the decades to come, and could help shape and monitor the initiative to eliminate cervical cancer as a major public health problem.
Journal ArticleDOI
Metaprop: a Stata command to perform meta-analysis of binomial data
TL;DR: Metaprop was applied on two published meta-analyses of HPV-infection in women with a Pap smear showing ASC-US and cure rate after treatment for cervical precancer using cold coagulation, both of which showed a pooled HPV-prevalence of 43%.
Journal ArticleDOI
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco,Joakim Dillner,K. Miriam Elfström,Sara Tunesi,Peter J.F. Snijders,Marc Arbyn,Henry C Kitchener,Nereo Segnan,Clare Gilham,Paolo Giorgi-Rossi,Johannes Berkhof,Julian Peto,Chris J.L.M. Meijer +12 more
TL;DR: Data of large-scale randomised trials support initiation of HPV-based screening from age 30 years and extension of screening intervals to at least 5 years, and provide 60-70% greater protection against invasive cervical carcinomas compared with cytology.
Journal ArticleDOI
Carcinogenic human papillomavirus infection.
Mark Schiffman,John Doorbar,Nicolas Wentzensen,Silvia de Sanjosé,Carole Fakhry,Bradley J. Monk,Margaret Stanley,Silvia Franceschi +7 more
TL;DR: HPV testing will probably replace cytology-based cervical screening owing to greater reassurance when the test is negative, however, the effective implementation of HPV vaccination and screening globally remains a challenge.
Journal ArticleDOI
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Rebecca B. Perkins,Richard S. Guido,Philip E. Castle,David Chelmow,Mark H. Einstein,Francisco A.R. Garcia,Warner K. Huh,Jane J. Kim,Anna-Barbara Moscicki,Ritu Nayar,Mona Saraiya,George F. Sawaya,Nicolas Wentzensen,Mark Schiffman +13 more
TL;DR: The 2019 ASCCP Risk-Based Management Consensus Guidelines Committee concluded that the current consensus on risk-based management guidelines is inadequate and called for further work on this issue.
References
More filters
Journal ArticleDOI
The causal relation between human papillomavirus and cervical cancer
TL;DR: It is the right time for medical societies and public health regulators to consider the causal role of human papillomavirus infections in cervical cancer and to define its preventive and clinical implications.
Journal ArticleDOI
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow,Diane Solomon,Herschel W. Lawson,Maureen Killackey,Shalini L Kulasingam,Joanna M. Cain,Francisco A.R. Garcia,Ann T. Moriarty,Alan G. Waxman,David C. Wilbur,Nicolas Wentzensen,Levi S. Downs,Mark Spitzer,Anna-Barbara Moscicki,Eduardo L. Franco,Mark H. Stoler,Mark Schiffman,Philip E. Castle,Evan R. Myers +18 more
TL;DR: An update to the ACS guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented, addressing age‐appropriate screening strategies, including the use of cytology and high‐risk human papillomavirus (HPV) testing.
Journal ArticleDOI
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
Michelle J. Khan,Philip E. Castle,Attila T. Lorincz,Sholom Wacholder,Mark S. Sherman,David R. Scott,Brenda R. Rush,Andrew G. Glass,Mark Schiffman +8 more
TL;DR: HPV screening that distinguishes HPV16 and HPV18 from other oncogenic HPV types may identify women at the greatest risk of > or = CIN3 and may permit less aggressive management of other women with onCogenic HPV infections.
Journal ArticleDOI
HPV screening for cervical cancer in rural India.
Rengaswamy Sankaranarayanan,Bhagwan M. Nene,Surendra S Shastri,Kasturi Jayant,Richard Muwonge,Atul Budukh,Sanjay Hingmire,Sylla G. Malvi,Ranjit Thorat,Ashok Kothari,Roshan F. Chinoy,Rohini Kelkar,Shubhada Kane,Sangeetha Desai,Vijay R Keskar,Raghevendra Rajeshwarkar,Nandkumar S Panse,Ketayun A. Dinshaw +17 more
TL;DR: In a low-resource setting, a single round of HPV testing was associated with a significant reduction in the numbers of advanced cervical cancers and deaths from cervical cancer.
Journal ArticleDOI
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
Marie-Hélène Mayrand,Eliane Duarte-Franco,Isabel Rodrigues,Stephen D. Walter,James A. Hanley,Alex Ferenczy,Sam Ratnam,François Coutlée,Eduardo L. Franco +8 more
TL;DR: HPV testing has greater sensitivity for the detection of cervical intraepithelial neoplasia than Pap testing, and Triage procedures for Pap or HPV testing resulted in fewer referrals for colposcopy than did either test alone but were less sensitive.
Related Papers (5)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
HPV screening for cervical cancer in rural India.
Rengaswamy Sankaranarayanan,Bhagwan M. Nene,Surendra S Shastri,Kasturi Jayant,Richard Muwonge,Atul Budukh,Sanjay Hingmire,Sylla G. Malvi,Ranjit Thorat,Ashok Kothari,Roshan F. Chinoy,Rohini Kelkar,Shubhada Kane,Sangeetha Desai,Vijay R Keskar,Raghevendra Rajeshwarkar,Nandkumar S Panse,Ketayun A. Dinshaw +17 more